Japan Biopharma
Partnering Conference

Conrad Hotel
Tokyo, Japan
October 25, 2016

Program

We designed the conference to give all attendees an opportunity to meet with presenters. The agenda begins with a welcome from Sofinnova Ventures, followed by sessions from the presenting companies.

October 25th, 2016 Track A (Nami) Track B (Nagisa)
7:00 a.m. – 9:00 a.m. Registration
9:00 a.m. – 9:15 a.m. Welcome Mike Powell, PhD, General Partner, Sofinnova Ventures (Nami)
9:15 a.m.
9:35 a.m.
9:55 a.m.
10:15 a.m.
10:35 a.m.
Probiodrug
Celdara Medical
ArmaGen
Xalud Therapeutics
ReNeuron
eTheRNA Immunotherapies
Abgenomics International
Checkmate Pharmaceuticals
OncoSec Medical
Sorrento Therapeutics
10:55 a.m. – 11:15 a.m. Break & Networking
11:15 a.m.
11:35 a.m.
11:55 p.m.
12:15 p.m.
Histogenics
Dimension Therapeutics
Amryt Pharma
Retrophin
Spectrum Pharmaceuticals
Nucana
Avidity Biosciences
Gritstone Oncology
12:35 p.m. – 1:20 p.m. Lunch (Nagi on 2nd Floor)
1:20 p.m. Remarks Sougato Das, Director, Partnering, Business Development, BIO (Nami)
1:35 p.m. Presentation Citigroup Global Markets (Nami)
1:55 p.m. – 2:45 p.m. Presentation and panel: Rare disease drug development and commercialization from a global perspective Moderated by Sunil Agarwal, MD, Partner, Sofinnova Ventures (Nami)

Panelists:
Michele Bellandi, CMO, Amryt Pharma
Bharatt Chowria, President, Synlogic
Ken Clark, Partner, Wilson Sonsini Goodrich & Rosati
Mary Thistle, CBO, Dimension Therapeutics
Jesse Shefferman, V.P, Business Development, Retrophin
David Snyder, Partner, Pillsbury
2:45 p.m.
3:05 p.m.
3:25 p.m.

3:45 p.m.
Synlogic
Allena Pharma
Ardelyx

Arena Pharmaceuticals
Principia Biopharma
Aquinox Pharmaceuticals
Provectus Biopharmaceuticals
Karyopharm Therapeutics
4:05 p.m. – 4:25 p.m. Break & Networking
4:25 p.m.
4:45 p.m.

5:05 p.m.
Dicerna Pharmaceuticals
Velocity Pharmaceutical Development
Prolacta Bioscience
Asterias Biotherapeutics
Sunesis

Opsona Therapeutics
5:30 p.m. – 7:30 p.m. Cocktail Reception (Lounge TwentyEight, across from the Conrad lobby)
  • Event
  • Event
  • Event
  • Event
  • Event